Literature DB >> 23384721

Predictors of fear of recurrence in patients one year after cancer rehabilitation: a prospective study.

Anja Mehnert1, Uwe Koch, Christin Sundermann, Andreas Dinkel.   

Abstract

BACKGROUND: Fear of cancer recurrence (FCR) or cancer progression is one of the most frequent distressing psychological symptoms in cancer patients. In contrast to anxiety disorders according to the ICD-10 or DSM-IV, FCR describes an emotional response to the real threat of a life-threatening illness. Elevated levels of FCR can become dysfunctional, causing considerable disruption in social functioning, and affect well-being and quality of life (QoL). We examined the prevalence and course of FCR in cancer patients during and after a rehabilitation program, and investigated associations between demographic, medical and psychosocial factors. We further aimed to identify predictors of FCR one year after cancer rehabilitation.
METHODS: A total of eligible N = 1281 patients (77.5% participation rate) were consecutively recruited on average 11 months post-diagnosis and assessed at the beginning (t1) (1148), at the end (t2) (1060) and 12 months after rehabilitation (t3) (n = 883). Participants completed validated measures assessing FCR, anxiety, depression, QoL, social support, and a range of cancer- and treatment-related characteristics.
RESULTS: At t1, 18.1% of our sample was classified as having high levels of FCR and 66.6% showed moderate levels of FCR. Fear of recurrence decreased over time (p < 0.001) (η² = .095), however, at follow-up 17.2% of our sample showed high levels of FCR and 67.6% had moderate levels of FCR. Linear regression analysis (stepwise backward) including demographic, medical and psychosocial factors, revealed that lower social class, having skin cancer, colon cancer or hematological cancer, palliative treatment intention, pain and a higher number of physical symptoms, depression, lower social support and adverse social interactions predicted FCR one year after rehabilitation (R² adjusted = 0.34) (p < 0.001).
CONCLUSION: Our data provide evidence that elevated levels of FCR represent a continuing problem in cancer patients. The need to enhance cancer rehabilitation and survivorship programs including interventions tailored to specific problems such as FCR is emphasized.

Entities:  

Mesh:

Year:  2013        PMID: 23384721     DOI: 10.3109/0284186X.2013.765063

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  32 in total

Review 1.  Mindfulness in Follow-Up Care After Breast Cancer: Can It Prevent Recurrence?

Authors:  Carola Modica; Klaus Hoenig
Journal:  Breast Care (Basel)       Date:  2018-04-20       Impact factor: 2.860

2.  A Systematic Review of Interventions for Health Anxiety Presentations Across Diverse Chronic Illnesses.

Authors:  Danielle Petricone-Westwood; Georden Jones; Brittany Mutsaers; Caroline Séguin Leclair; Christina Tomei; Geneviève Trudel; Andreas Dinkel; Sophie Lebel
Journal:  Int J Behav Med       Date:  2019-02

3.  Prevalence and factors associated with fear of recurrence in a mixed sample of young adults with cancer.

Authors:  Breanna E Lane; Sheila N Garland; Karine Chalifour; Geoff Eaton; Sophie Lebel; Jacqueline Galica; Christine Maheu; Sébastien Simard
Journal:  J Cancer Surviv       Date:  2019-08-29       Impact factor: 4.442

4.  The initial clinical interview--can it reduce cancer patients' fear?

Authors:  Sophie Elisabeth Groß; Anika Nitzsche; Tristan D Gloede; Lena Ansmann; Richard Street; Holger Pfaff; Melanie Neumann; Markus Wirtz; Walter Baumann; Stephan Schmitz; Nicole Ernstmann
Journal:  Support Care Cancer       Date:  2014-09-25       Impact factor: 3.603

5.  Fear of recurrence and its impact on quality of life in patients with hematological cancers in the course of allogeneic hematopoietic SCT.

Authors:  S Sarkar; A Scherwath; L Schirmer; F Schulz-Kindermann; K Neumann; M Kruse; A Dinkel; S Kunze; F Balck; N Kröger; U Koch; A Mehnert
Journal:  Bone Marrow Transplant       Date:  2014-07-07       Impact factor: 5.483

6.  Trajectories of fear of recurrence in women with breast cancer.

Authors:  Laura B Dunn; Dale J Langford; Steven M Paul; Molly B Berman; Dianne M Shumay; Kord Kober; John D Merriman; Claudia West; John M Neuhaus; Christine Miaskowski
Journal:  Support Care Cancer       Date:  2014-12-19       Impact factor: 3.603

7.  Preferences and Utilities for Health States after Treatment of Olfactory Groove Meningioma: Endoscopic versus Open.

Authors:  Christopher M Yao; Alyssa Kahane; Eric Monteiro; Fred Gentili; Gelareh Zadeh; John R de Almeida
Journal:  J Neurol Surg B Skull Base       Date:  2017-02-17

8.  Fear of disease progression in adult ambulatory patients with brain cancer: prevalence and clinical correlates.

Authors:  Simone Goebel; Hubertus Maximilian Mehdorn
Journal:  Support Care Cancer       Date:  2019-01-25       Impact factor: 3.603

9.  Group-based trajectory modeling of fear of disease recurrence among women recently diagnosed with gynecological cancers.

Authors:  Sharon L Manne; Shannon Myers-Virtue; David Kissane; Melissa L Ozga; Deborah A Kashy; Stephen C Rubin; Norman G Rosenblum; Carolyn J Heckman
Journal:  Psychooncology       Date:  2016-08-09       Impact factor: 3.894

10.  NCCN Guidelines Insights: Survivorship, Version 1.2016.

Authors:  Crystal S Denlinger; Jennifer A Ligibel; Madhuri Are; K Scott Baker; Gregory Broderick; Wendy Demark-Wahnefried; Debra L Friedman; Mindy Goldman; Lee W Jones; Allison King; Grace H Ku; Elizabeth Kvale; Terry S Langbaum; Mary S McCabe; Michelle Melisko; Jose G Montoya; Kathi Mooney; Mary Ann Morgan; Javid J Moslehi; Tracey O'Connor; Linda Overholser; Electra D Paskett; Jeffrey Peppercorn; M Alma Rodriguez; Kathryn J Ruddy; Tara Sanft; Paula Silverman; Sophia Smith; Karen L Syrjala; Susan G Urba; Mark T Wakabayashi; Phyllis Zee; Nicole R McMillian; Deborah A Freedman-Cass
Journal:  J Natl Compr Canc Netw       Date:  2016-06       Impact factor: 11.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.